PQ 182
254 Deputy Paul Gogarty asked the Minister for Health and Children if there are plans to review the permission for a drug (details supplied) here, in view of the fact that it has received a black box warning by the US Food and Drink Administration; if her attention has been drawn to the research that points to significant and potentially life threatening side effects that are in excess of any standard benefits outweigh risk argument regarding usage of this long-term reproductive system controlling substance; and if she will make a statement on the matter. [23541/07]
Introduced
16 October 2007
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
16 October 2007
Summary
254 Deputy Paul Gogarty asked the Minister for Health and Children if there are plans to review the permission for a drug (details supplied) here, in view of the fact that it has received a black box warning by the US Food and Drink Administration; if her attention has been drawn to the research that points to significant and potentially life threatening side effects that are in excess of any standard benefits outweigh risk argument regarding usage of this long-term reproductive system controlling substance; and if she will make a statement on the matter. [23541/07]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products.
Medicinal Products.
xml · EN · 16 October 2007
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2007-10-16/182/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2007-10-16/pq_182